The medtech startup, founded in 2015, hopes to reduce occurences of brain haemorrhage by treating intracranial aneurysms.
Oxford Endovascular has raised €9.4M across 1 funding round, most recently a Series A round in May 2024. Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-05-20 | Series A | €9.4M |
| — |
| View deal → |
